- Associate Professor, Pharmacotherapy
- Director of Clinical Pharmacy Operations
Biography
Education and Certifications
- Doctor of Pharmacy, University of New Mexico
- MBA, Washington State University
- Medical Assistant Phlebotomist Certification
- Community & Equity Certification
- Registered Pharmacist, Washington, New Mexico
- APhA Pain Management and Safer Opioid Use Certification
- Advanced Teaching Certification
- Medication Therapy Management Certification
- National Immunization Training Certification
- Clinical Community Pharmacist Certification
- REMS SAFE Opioid Prescribing Certification
About Me
Within my role at WSU, I have the opportunity to teach, practice clinically and pursue research. Within the PharmD curriculum, I teach a variety of required courses such as Health Care Systems for Pharmacists and Pharmacy Management, and deliver lectures on substance use disorders. I also teach an elective course specializing in substance use disorders. I practice clinically treating patients with substance use disorders as the on site clinical lead for the WSU Research Clinic where we see patients enrolled in clinical trials for innovative ways to treat substance use disorders. I am deeply committed to community outreach, delivering naloxone trainings, and advocating for evidence-based medicine in a culturally equitable manner.
In my spare time I like to…
I love to hike, to run (mostly long distances) and to hang out with my dog and husband!
Why WSU?
I love the Coug culture. There is a connectedness within WSU where you feel like you belong. I really appreciate the support that comes with that network.
My Favorite Quote
“I would like to be remembered as someone who used whatever talent she had to do her work to the very best of her ability.” – Ruth Bader Ginsburg
Awards
- Patient Care Award, University of New Mexico College of Pharmacy (May 2017)
- University of Washington MEDEX Physician Assistant Program Golden Apple Speaker Award (February 2018)
- Spokane Pharmacy Association Pharmacist of the Year (February 2019)
- University of Washington MEDEX Physician Assistant Program Golden Apple Speaker Award (February 2020)
- Washington State University College of Pharmacy and Pharmaceutical Sciences PY4 Faculty Preceptor of the Year (May 2021)
- Washington State University Chancellor’s Excellence Award, Diversity, Equity & Inclusion (April 2022)
Selected Publications
Peer Reviewed Journal Articles: https://orcid.org/0000-0001-9522-3677
McPherson, S. Smith, C.L., Hall, L., Miguel, A., Bowden, T., Keever, A., Schmidt, A., Olson, K., Rodin, N., McDonell, M.G., Roll, J.M., LeBrun, J. (in press). Mobile Medication Adherence Platform for Buprenorphine (MAP4BUP): A Pilot Feasibility, Usability and Efficacy Randomized Clinical Trial. Drug and Alcohol Dependence.
Miguel AQC, Smith C, Rodin NM, Johnson K, McDonell MG, McPherson SM. Automated Reinforcement Management System: Feasibility study findings of an app-based contingency management treatment for alcohol use disorder. Drug and Alcohol Dependence Reports. In press.
Smith, C.L., Keever, A., Bowden, T., Olson, K., Rodin, NM., McDonell, M.G., Roll, J.M., Smoody, G., LeBrun, J., Miguel, A.Q.C., McPherson, S.M. (In press) Patient Feedback on a Mobile Medication Adherence Application for Buprenorphine/Naloxone: Closed and Open-Ended Survey on Feasibility and acceptability study. JMIR Formative Research.
Smith, C.L., Rodin, NM, Hwang, J.Y. et al. Automated Reinforcement Management System (ARMS): focused phase I provider feedback. Addict Sci Clin Pract 17, 20 (2022). https://doi.org/10.1186/s13722-022-00301-w.
Rodin NM, Bertsch TG, Frazier KR, McKeirnan KC. Utilizing an optional cumulative examination in a skills-based lab course series to assess student performance and knowledge retention. Curr Pharm Teach Learn. 2022 Apr;14(4):432-439. doi: 10.1016/j.cptl.2022.03.006. Epub 2022 Mar 14. PMID: 35483808.
Miguel A, Smith C, Perea NM, Johnson K, McDonell M, McPherson S. Development of Automated Reinforcement Management System (ARMS): Protocol for a Phase I Feasibility and Usability Study. JMIR Formative Research. 31/05/2021:25796 2021 June 1.
Miller JC, Rodin NM, McKeirnan KC. Training student pharmacists to administer pediatric immunizations. Curr Pharm Teach Learn. 2022 Apr;14(4):507-513. doi: 10.1016/j.cptl.2022.03.007. Epub 2022 Mar 24. PMID: 35483818.
Adams JL, Law AV, Kawahara B, Godwin DA, Marrs JC, Ross LA, Rodin N, Shipman AJ, Cárdenas J. Report of the 2020-2021 Strategic Engagement Standing Committee. Am J Pharm Educ. 2021 Nov;85(10):8715. doi: 10.5688/ajpe8715. Epub 2021 Jul 22. PubMed PMID: 34301579; PubMed Central PMCID: PMC8715961.
Bertsch TG, Denton TT, Perea NM, Ahmed A, McKeirnan KC. Drug development and the process of transitioning to team-based learning in a qualitative way. Curr Pharm Teach Learn. 2021 Feb; ISSN 1877-1297, https://doi.org/10.1016/j.cptl.2021.01.025.
Perea NM, Bertsch TG, McKeirnan KC. Considerations in training student pharmacists to perform physical assessment. Curr Pharm Teach Learn. 2020 May;12(5):577-584. doi: 10.1016/j.cptl.2020.01.002. Epub 2020 Jan 31. PMID: 32336456.
Grants
Rural Opioid Technical Assistance Collaborative (ROTAC) (SAMHSA). Hirchak, K, Liat K, Parent S, Rodin NM (Co-Investigator 0.10 FTE), Martinez A, Cooper B, Weybright E, McDonell M. H79 TI082255. October 2022-September 2025. Description: The Northwest Rural Opioid Technical Assistance Collaborative (NW ROTAC) is a partnership between Washington State University’s Center for Rural Opioid Prevention, Treatment, and Recovery (CROP+TR) and Oregon State University’s Coast to Forest with the goal of developing and disseminating training and technical assistance (TTA) to rural communities for prevention, treatment, and recovery from opioid misuse.
Pharmaceutically Enhanced Reinforcement for Reduced Alcohol and Smoking. McDonnel M, Smith C, Burduli E, Constantino A, Rodin NM (Co-Investigator, 0.15 FTE), Chaylor N, Roll J, Layton M, McPherson S. April 2021-March 2026. Description: Our aim is to investigate the combined implementation of two highly promising treatments for comorbid alcohol and nicotine addiction – contingency management and varenicline – as a high-intensity intervention to treat drinking and smoking simultaneously.
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuro-Clinical Assessment Framework. Smith C, McDonnel M, Constantino A, Rodin NM (Co-Investigator, 0.15 FTE), Roll J, Layton M, McPherson S. R01 AA028796-01. September 2020-July 2025. Description: Our aim is to investigate zonisamide as a novel therapy for the treatment of alcohol use disorder using objectively verified urinary abstinence with EtG cups among patients with an alcohol use disorder who will also receive standard, bibliotherapy treatment.